Literature DB >> 9973048

An analysis of blood management in patients having a total hip or knee arthroplasty.

B E Bierbaum1, J J Callaghan, J O Galante, H E Rubash, R E Tooms, R B Welch.   

Abstract

Three hundred and thirty orthopaedic surgeons in the United States participated in a study of transfusion requirements associated with total joint arthroplasty. A total of 9482 patients (3920 patients who had a total hip replacement and 5562 patients who had a total knee replacement) were evaluated prospectively from September 1996 through June 1997. Of those patients, 4409 (46 percent [57 percent of the patients who had a hip replacement and 39 percent of the patients who had a knee replacement]) had a blood transfusion. Two thousand eight hundred and ninety patients (66 percent) received autologous blood, and 1519 patients (34 percent) received allogenic blood. Ordered logistic regression analysis showed the most important predictors of the transfusion of allogenic blood to be a low baseline hemoglobin level and a lack of predonated autologous blood. Preoperative donation of autologous blood decreases the risk of transfusion of allogenic blood; however, inefficiencies in the procedures for obtaining autologous blood were identified. Sixty-one percent (5741) of the patients had predonated blood for autologous transfusion, but 4464 (45 percent) of the 9920 units of the predonated autologous blood were not used. Primary procedures and revision total knee arthroplasty were associated with the greatest number of wasted autologous units. Of the 5741 patients who had predonated blood, 503 (9 percent) needed a transfusion of allogenic blood. The frequency of allogenic blood transfusion varied with respect to the type of operative procedure (revision total hip arthroplasty and bilateral total knee arthroplasty were associated with the highest prevalence of such transfusions) and with a baseline hemoglobin level of 130 grams per liter or less. Transfusion of allogenic blood was also associated with infection (p < or = 0.001), fluid overload (p < or = 0.001), and increased duration of hospitalization (p < or = 0.01). These latter findings warrant further evaluation in controlled studies.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9973048     DOI: 10.2106/00004623-199901000-00002

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  216 in total

Review 1.  Blood management and patient specific transfusion options in total joint replacement surgery.

Authors:  J J Callaghan; A I Spitzer
Journal:  Iowa Orthop J       Date:  2000

2.  Preoperative factors and early complications associated with hemiarthroplasty and total hip arthroplasty for displaced femoral neck fractures.

Authors:  Christopher P Miller; Rafael A Buerba; Michael P Leslie
Journal:  Geriatr Orthop Surg Rehabil       Date:  2014-06

3.  Transfusion drains versus suction drains in total knee replacement: meta-analysis.

Authors:  Sheraz R Markar; Gareth G Jones; Alan Karthikesalingam; Nicholas Segaren; Rahul V Patel
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-11-10       Impact factor: 4.342

Review 4.  Transfusion of post-operative shed blood: laboratory characteristics and clinical utility.

Authors:  M Muñoz; J J García-Vallejo; M D Ruiz; R Romero; E Olalla; C Sebastián
Journal:  Eur Spine J       Date:  2004-05-08       Impact factor: 3.134

5.  Minimally invasive total hip arthroplasty using a transpiriformis approach: a preliminary report.

Authors:  Douglas J Roger; David Hill
Journal:  Clin Orthop Relat Res       Date:  2012-01-04       Impact factor: 4.176

6.  Efficacy and cost-effectiveness of a blood salvage system in primary total knee arthroplasty--a retrospective match-controlled chart review.

Authors:  Clifford Kent Boese; Theresa J Gallo; Marcia Weis; Rebecca Baker; Carla J Plantikow; Brian Cooley
Journal:  Iowa Orthop J       Date:  2011

Review 7.  Laboratory characteristics and clinical utility of post-operative cell salvage: washed or unwashed blood transfusion?

Authors:  Manuel Muñoz; Robert Slappendel; Dafydd Thomas
Journal:  Blood Transfus       Date:  2010-09-14       Impact factor: 3.443

Review 8.  Total joint replacement and blood loss: what is the best equation?

Authors:  Emmanuel Gibon; Jean-Pierre Courpied; Moussa Hamadouche
Journal:  Int Orthop       Date:  2013-02-06       Impact factor: 3.075

9.  On the relevance of preoperative haemoglobin optimisation within a Patient Blood Management programme for elective hip arthroplasty surgery.

Authors:  Cristian Pinilla-Gracia; Jesús Mateo-Agudo; Antonio Herrera; Manuel Muñoz
Journal:  Blood Transfus       Date:  2020-04-10       Impact factor: 3.443

10.  Efficacy and economics of postoperative blood salvage in patients undergoing elective total hip replacement.

Authors:  Saqeb B Mirza; Jon Campion; John H Dixon; Sukhmeet S Panesar
Journal:  Ann R Coll Surg Engl       Date:  2007-11       Impact factor: 1.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.